ESR2 and breast cancer: Furthermore, the level of ERβ and its co-expression with ERα has been suggested to modulate the cell’s response to estrogen in BC cell lines and may also modulate the response of ER+ BC to endocrine therapy (Song et al., 2019; Mal et al., 2020; Datta et al., 2022).